id	sid	eid	entity	type
ajlsi-2730	1	1	1	CARDINAL
ajlsi-2730	1	2	69	CARDINAL
ajlsi-2730	1	3	american journal of life science	ORG
ajlsi-2730	1	4	il-17a	PRODUCT
ajlsi-2730	1	5	hamza ahmed elsayed1*	PERSON
ajlsi-2730	1	6	rabab elsayed ali hassan khater2	PERSON
ajlsi-2730	1	7	3	CARDINAL
ajlsi-2730	1	8	1,	DATE
ajlsi-2730	1	9	2024	CARDINAL
ajlsi-2730	1	10	2833-1397	CARDINAL
ajlsi-2730	1	11	https://journals.e-palli.com/home/index.php/ajlsi	PERSON
ajlsi-2730	1	12	may 01	DATE
ajlsi-2730	1	13	2024	DATE
ajlsi-2730	1	14	may 31	DATE
ajlsi-2730	1	15	2024	CARDINAL
ajlsi-2730	1	16	june 04	DATE
ajlsi-2730	1	17	2024	CARDINAL
ajlsi-2730	4	1	il-17a	PRODUCT
ajlsi-2730	4	2	30	CARDINAL
ajlsi-2730	4	3	6-12 years	DATE
ajlsi-2730	4	4	uae	GPE
ajlsi-2730	4	5	5 months	DATE
ajlsi-2730	7	1	five months	DATE
ajlsi-2730	7	2	45 to 50%	PERCENT
ajlsi-2730	9	1	0.05	CARDINAL
ajlsi-2730	12	1	il-17a	PRODUCT
ajlsi-2730	13	1	secukinumab	GPE
ajlsi-2730	15	1	one	CARDINAL
ajlsi-2730	15	2	2020	DATE
ajlsi-2730	17	1	lilly & bunick	ORG
ajlsi-2730	17	2	2023	CARDINAL
ajlsi-2730	20	1	generalized brown	PERSON
ajlsi-2730	20	2	xli	ORG
ajlsi-2730	21	1	li	PERSON
ajlsi-2730	21	2	collodion	ORG
ajlsi-2730	21	3	2022	CARDINAL
ajlsi-2730	25	1	xli	ORG
ajlsi-2730	25	2	2013	DATE
ajlsi-2730	27	1	1	CARDINAL
ajlsi-2730	27	2	uae	GPE
ajlsi-2730	27	3	2	CARDINAL
ajlsi-2730	27	4	uae	GPE
ajlsi-2730	27	5	ge	ORG
ajlsi-2730	27	6	70 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-2730	28	1	j. life sci	PERSON
ajlsi-2730	28	2	innov	PERSON
ajlsi-2730	29	1	3(1	CARDINAL
ajlsi-2730	29	2	69	CARDINAL
ajlsi-2730	29	3	2024	CARDINAL
ajlsi-2730	31	1	czarnowicki et al.	PERSON
ajlsi-2730	31	2	2018	DATE
ajlsi-2730	31	3	kim et al.	PERSON
ajlsi-2730	31	4	2022	CARDINAL
ajlsi-2730	31	5	2019	DATE
ajlsi-2730	32	1	tnf	CARDINAL
ajlsi-2730	32	2	il-17a	PRODUCT
ajlsi-2730	33	1	il-17a	PRODUCT
ajlsi-2730	34	1	2023	CARDINAL
ajlsi-2730	34	2	2019	DATE
ajlsi-2730	34	3	wang et al.	PERSON
ajlsi-2730	34	4	2021	CARDINAL
ajlsi-2730	35	1	il-17a	PRODUCT
ajlsi-2730	35	2	adalimumab	PERSON
ajlsi-2730	35	3	secukinumab	PERSON
ajlsi-2730	35	4	ixekizumab	PERSON
ajlsi-2730	35	5	il-17a	PRODUCT
ajlsi-2730	35	6	il12	PRODUCT
ajlsi-2730	35	7	23	CARDINAL
ajlsi-2730	35	8	2017	CARDINAL
ajlsi-2730	35	9	2023	CARDINAL
ajlsi-2730	35	10	2021	CARDINAL
ajlsi-2730	36	1	il-17a	PRODUCT
ajlsi-2730	40	1	2023	CARDINAL
ajlsi-2730	42	1	2021	CARDINAL
ajlsi-2730	44	1	2022	CARDINAL
ajlsi-2730	45	1	secukinumab	PERSON
ajlsi-2730	45	2	48%	PERCENT
ajlsi-2730	45	3	2021	CARDINAL
ajlsi-2730	46	1	keratolytics	PERSON
ajlsi-2730	46	2	2021	CARDINAL
ajlsi-2730	49	1	12%	PERCENT
ajlsi-2730	49	2	5–10%	PERCENT
ajlsi-2730	50	1	ahas	ORG
ajlsi-2730	50	2	corneocyte	GPE
ajlsi-2730	50	3	palmer & dunwell	ORG
ajlsi-2730	50	4	2022	CARDINAL
ajlsi-2730	54	1	0.5% to 30% and 6%	PERCENT
ajlsi-2730	54	2	2020	DATE
ajlsi-2730	56	1	first	ORDINAL
ajlsi-2730	56	2	2020	DATE
ajlsi-2730	59	1	80%	PERCENT
ajlsi-2730	60	1	2012	DATE
ajlsi-2730	62	1	2013	DATE
ajlsi-2730	66	1	400	CARDINAL
ajlsi-2730	66	2	600	CARDINAL
ajlsi-2730	66	3	60,000	CARDINAL
ajlsi-2730	66	4	daily	DATE
ajlsi-2730	66	5	10 days	DATE
ajlsi-2730	67	1	2016	DATE
ajlsi-2730	68	1	acitretin	PERSON
ajlsi-2730	68	2	71 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-2730	69	1	j. life sci	PERSON
ajlsi-2730	69	2	innov	PERSON
ajlsi-2730	70	1	3(1	CARDINAL
ajlsi-2730	71	1	69	CARDINAL
ajlsi-2730	71	2	2024	DATE
ajlsi-2730	71	3	2016	DATE
ajlsi-2730	72	1	acitretin 0.5 mg/kg/	PERSON
ajlsi-2730	72	2	1 mg/kg	QUANTITY
ajlsi-2730	72	3	two months	DATE
ajlsi-2730	73	1	1 mg/kg	QUANTITY
ajlsi-2730	73	2	half	CARDINAL
ajlsi-2730	73	3	2021	CARDINAL
ajlsi-2730	74	1	harlequin ichthyosis	PERSON
ajlsi-2730	74	2	baldo et al.	PERSON
ajlsi-2730	74	3	2021	CARDINAL
ajlsi-2730	75	1	adalimumab	PERSON
ajlsi-2730	76	1	2020	DATE
ajlsi-2730	79	1	2021	CARDINAL
ajlsi-2730	79	2	2021	CARDINAL
ajlsi-2730	79	3	2017	DATE
ajlsi-2730	81	1	secukinumab	PERSON
ajlsi-2730	81	2	48%	PERCENT
ajlsi-2730	81	3	6-month	DATE
ajlsi-2730	82	1	2024	CARDINAL
ajlsi-2730	82	2	narbutt et al.	PERSON
ajlsi-2730	82	3	2023	CARDINAL
ajlsi-2730	82	4	2021	CARDINAL
ajlsi-2730	83	1	approximately 95%	PERCENT
ajlsi-2730	83	2	ixekizumab	PERSON
ajlsi-2730	84	1	2022	CARDINAL
ajlsi-2730	85	1	interleukin-13	DATE
ajlsi-2730	86	1	afshan & kelbel	ORG
ajlsi-2730	86	2	2019	DATE
ajlsi-2730	86	3	2023	CARDINAL
ajlsi-2730	86	4	martin-garcía et al.	ORG
ajlsi-2730	86	5	2023	CARDINAL
ajlsi-2730	87	1	2023	CARDINAL
ajlsi-2730	88	1	ustekinumab	PERSON
ajlsi-2730	88	2	15-year-old	DATE
ajlsi-2730	88	3	harlequin ichthyosis	PERSON
ajlsi-2730	89	1	one month	DATE
ajlsi-2730	90	1	a year	DATE
ajlsi-2730	91	1	2023	CARDINAL
ajlsi-2730	92	1	il-17a	PRODUCT
ajlsi-2730	93	1	30	CARDINAL
ajlsi-2730	93	2	6-12 years	DATE
ajlsi-2730	93	3	uae	GPE
ajlsi-2730	93	4	5 months	DATE
ajlsi-2730	93	5	november to february 2024	DATE
ajlsi-2730	94	1	between the ages of 6	DATE
ajlsi-2730	99	1	th17	PRODUCT
ajlsi-2730	99	2	il-17a	PRODUCT
ajlsi-2730	101	1	th1	ORG
ajlsi-2730	103	1	il17	ORG
ajlsi-2730	103	2	three	CARDINAL
ajlsi-2730	104	1	il-17a	PRODUCT
ajlsi-2730	104	2	secukinumab	PERSON
ajlsi-2730	104	3	ixekizumab	PERSON
ajlsi-2730	104	4	6 to 12 years old	DATE
ajlsi-2730	105	1	72 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-2730	106	1	j. life sci	PERSON
ajlsi-2730	106	2	innov	PERSON
ajlsi-2730	107	1	3(1	CARDINAL
ajlsi-2730	107	2	69	CARDINAL
ajlsi-2730	107	3	2024	CARDINAL
ajlsi-2730	107	4	5 months	DATE
ajlsi-2730	107	5	45 to 50 percent	PERCENT
ajlsi-2730	109	1	secukinumab	PERSON
ajlsi-2730	109	2	fda	ORG
ajlsi-2730	111	1	45%	PERCENT
ajlsi-2730	111	2	6 months	DATE
ajlsi-2730	112	1	secukinumab secukinumab	GPE
ajlsi-2730	116	1	secukinumab	GPE
ajlsi-2730	117	1	secukinumab	GPE
ajlsi-2730	118	1	0.05	CARDINAL
ajlsi-2730	119	1	secukinumab	GPE
ajlsi-2730	120	1	il17	ORG
ajlsi-2730	121	1	secukinumab	PERSON
ajlsi-2730	122	1	secukinumab	PERSON
ajlsi-2730	123	1	secukinumab	GPE
ajlsi-2730	123	2	45%	PERCENT
ajlsi-2730	124	1	secukinumab	PERSON
ajlsi-2730	134	1	adalimumab	PERSON
ajlsi-2730	134	2	infliximab	GPE
ajlsi-2730	134	3	secukinumab	PERSON
ajlsi-2730	134	4	ixekizumab	PERSON
ajlsi-2730	137	1	30	CARDINAL
ajlsi-2730	137	2	uae	GPE
ajlsi-2730	137	3	november to february 2024	DATE
ajlsi-2730	138	1	6-12	DATE
ajlsi-2730	142	1	th1	ORG
ajlsi-2730	143	1	6-12	DATE
ajlsi-2730	144	1	il-17a	PRODUCT
ajlsi-2730	144	2	secukinumab	GPE
ajlsi-2730	145	1	5 months	DATE
ajlsi-2730	145	2	45-50%	PERCENT
ajlsi-2730	146	1	secukinumab	PERSON
ajlsi-2730	147	1	secukinumab	PERSON
ajlsi-2730	147	2	45%	PERCENT
ajlsi-2730	147	3	73 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-2730	148	1	j. life sci	PERSON
ajlsi-2730	148	2	innov	PERSON
ajlsi-2730	149	1	3(1	CARDINAL
ajlsi-2730	149	2	69	CARDINAL
ajlsi-2730	149	3	2024	CARDINAL
ajlsi-2730	151	1	secukinumab	PERSON
ajlsi-2730	161	1	12-month	DATE
ajlsi-2730	164	1	t., & kelbel	ORG
ajlsi-2730	164	2	t.	PERSON
ajlsi-2730	164	3	2019	DATE
ajlsi-2730	165	1	m501	PRODUCT
ajlsi-2730	166	1	123(5	CARDINAL
ajlsi-2730	166	2	h.	PERSON
ajlsi-2730	166	3	pao lin	PERSON
ajlsi-2730	166	4	t.	GPE
ajlsi-2730	166	5	lee	PERSON
ajlsi-2730	166	6	t. s.	GPE
ajlsi-2730	166	7	ooi	ORG
ajlsi-2730	166	8	d., & leong	ORG
ajlsi-2730	166	9	k. f.	PERSON
ajlsi-2730	166	10	2024	CARDINAL
ajlsi-2730	167	1	secukinumab	PERSON
ajlsi-2730	168	1	n.	ORG
ajlsi-2730	168	2	b. s.	PERSON
ajlsi-2730	168	3	alhamazani	PERSON
ajlsi-2730	168	4	r.	NORP
ajlsi-2730	168	5	s.	GPE
ajlsi-2730	168	6	alhomida	ORG
ajlsi-2730	168	7	f. a.	PERSON
ajlsi-2730	168	8	alasmari	GPE
ajlsi-2730	168	9	b., & alshammari	ORG
ajlsi-2730	168	10	r.	PERSON
ajlsi-2730	168	11	2023	CARDINAL
ajlsi-2730	169	1	harlequin ichthyosis	PERSON
ajlsi-2730	171	1	a. r.	PERSON
ajlsi-2730	171	2	shaheen	PERSON
ajlsi-2730	171	3	e. a.	PERSON
ajlsi-2730	171	4	alanazi	GPE
ajlsi-2730	171	5	alfawzan, a.	PERSON
ajlsi-2730	171	6	alharthi	ORG
ajlsi-2730	171	7	r., & alhomida	ORG
ajlsi-2730	171	8	f. a.	PERSON
ajlsi-2730	171	9	2023	CARDINAL
ajlsi-2730	173	1	jaad	PERSON
ajlsi-2730	173	2	39	DATE
ajlsi-2730	173	3	17	CARDINAL
ajlsi-2730	174	1	baldo	PERSON
ajlsi-2730	174	2	f.	PERSON
ajlsi-2730	174	3	brena	GPE
ajlsi-2730	174	4	m.	PERSON
ajlsi-2730	174	5	s.	GPE
ajlsi-2730	174	6	f.	GPE
ajlsi-2730	174	7	lanni	GPE
ajlsi-2730	174	8	s., guez	PERSON
ajlsi-2730	174	9	s.	PERSON
ajlsi-2730	174	10	petaccia	GPE
ajlsi-2730	174	11	a.	PERSON
ajlsi-2730	174	12	r., & filocamo	ORG
ajlsi-2730	174	13	g.	PERSON
ajlsi-2730	174	14	2021	CARDINAL
ajlsi-2730	175	1	harlequin ichthyosis	PERSON
ajlsi-2730	177	1	19(1	CARDINAL
ajlsi-2730	177	2	80	DATE
ajlsi-2730	178	1	barbati	ORG
ajlsi-2730	178	2	f.	PERSON
ajlsi-2730	178	3	m.	PERSON
ajlsi-2730	178	4	t.,	GPE
ajlsi-2730	178	5	lodi	GPE
ajlsi-2730	178	6	l.	GPE
ajlsi-2730	178	7	barni	GPE
ajlsi-2730	178	8	s., novembre	ORG
ajlsi-2730	178	9	e.	GPE
ajlsi-2730	178	10	baldo	PERSON
ajlsi-2730	178	11	m.	PERSON
ajlsi-2730	178	12	stagi	ORG
ajlsi-2730	178	13	s., & ricci	ORG
ajlsi-2730	178	14	s.	PERSON
ajlsi-2730	178	15	2021	CARDINAL
ajlsi-2730	180	1	9	CARDINAL
ajlsi-2730	180	2	645259	DATE
ajlsi-2730	181	1	blanchet‐bardon	GPE
ajlsi-2730	181	2	g.	PERSON
ajlsi-2730	181	3	machado matos	PERSON
ajlsi-2730	181	4	m., & delarue	ORG
ajlsi-2730	181	5	a.	PERSON
ajlsi-2730	181	6	2012	DATE
ajlsi-2730	183	1	the european academy	ORG
ajlsi-2730	183	2	26(8	CARDINAL
ajlsi-2730	183	3	1014-1019	DATE
ajlsi-2730	184	1	cicek	PERSON
ajlsi-2730	184	2	f.	PERSON
ajlsi-2730	184	3	cekic	PERSON
ajlsi-2730	184	4	s., & kilic	ORG
ajlsi-2730	184	5	s. s.	PERSON
ajlsi-2730	184	6	2021	CARDINAL
ajlsi-2730	185	1	infliximab	PERSON
ajlsi-2730	186	1	38(3	DATE
ajlsi-2730	186	2	714	CARDINAL
ajlsi-2730	187	1	cortés, h.	PERSON
ajlsi-2730	187	2	del prado-audelo	PERSON
ajlsi-2730	187	3	m. l.	PERSON
ajlsi-2730	187	4	z.	PERSON
ajlsi-2730	187	5	s.	PERSON
ajlsi-2730	187	6	gonzález-torres	PERSON
ajlsi-2730	187	7	m.	PERSON
ajlsi-2730	187	8	reyeshernández	PERSON
ajlsi-2730	187	9	o. d.	PERSON
ajlsi-2730	187	10	gonzález-del carmen	PERSON
ajlsi-2730	187	11	m., & leyva-gómez	ORG
ajlsi-2730	187	12	2020	DATE
ajlsi-2730	189	1	312	CARDINAL
ajlsi-2730	189	2	237	CARDINAL
ajlsi-2730	190	1	czarnowicki	PERSON
ajlsi-2730	190	2	t.	GPE
ajlsi-2730	190	3	leonard, a.	PERSON
ajlsi-2730	190	4	malik	PERSON
ajlsi-2730	190	5	k., magidi	PERSON
ajlsi-2730	190	6	s.	PERSON
ajlsi-2730	190	7	rangel	PERSON
ajlsi-2730	190	8	s.	PERSON
ajlsi-2730	190	9	patel	PERSON
ajlsi-2730	190	10	ramsey	PERSON
ajlsi-2730	190	11	k.	PERSON
ajlsi-2730	190	12	m., & song	ORG
ajlsi-2730	190	13	2018	DATE
ajlsi-2730	191	1	th17/tc-17	PRODUCT
ajlsi-2730	193	1	138(10	DATE
ajlsi-2730	193	2	2157	CARDINAL
ajlsi-2730	194	1	j. a.	PERSON
ajlsi-2730	194	2	m., & williams	ORG
ajlsi-2730	194	3	m.	PERSON
ajlsi-2730	194	4	2013	DATE
ajlsi-2730	196	1	26(1	CARDINAL
ajlsi-2730	196	2	1-15	CARDINAL
ajlsi-2730	197	1	gulasi, s.	PERSON
ajlsi-2730	197	2	2016	CARDINAL
ajlsi-2730	198	1	acitretin	PERSON
ajlsi-2730	199	1	iranian	NORP
ajlsi-2730	199	2	26(5	DATE
ajlsi-2730	200	1	ge	ORG
ajlsi-2730	200	2	74 https://journals.e-palli.com/home/index.php/ajlsi	QUANTITY
ajlsi-2730	201	1	j. life sci	PERSON
ajlsi-2730	201	2	innov	PERSON
ajlsi-2730	202	1	3(1	CARDINAL
ajlsi-2730	202	2	69	CARDINAL
ajlsi-2730	202	3	2024	CARDINAL
ajlsi-2730	202	4	c.	GPE
ajlsi-2730	202	5	e.	ORG
ajlsi-2730	202	6	a. s.	PERSON
ajlsi-2730	202	7	akiyama, m., mazereeuw-hautier	PERSON
ajlsi-2730	202	8	j.	PERSON
ajlsi-2730	202	9	a., & gonzález-sarmiento	ORG
ajlsi-2730	202	10	r.	PERSON
ajlsi-2730	202	11	2023	CARDINAL
ajlsi-2730	204	1	9(1	CARDINAL
ajlsi-2730	204	2	2	CARDINAL
ajlsi-2730	204	3	b.	PERSON
ajlsi-2730	204	4	martin-santiago	PERSON
ajlsi-2730	204	5	a., & garcia-doval	ORG
ajlsi-2730	204	6	i.	PERSON
ajlsi-2730	204	7	2013	DATE
ajlsi-2730	206	1	the american academy	ORG
ajlsi-2730	206	2	544	CARDINAL
ajlsi-2730	208	1	l.	PERSON
ajlsi-2730	208	2	li	PERSON
ajlsi-2730	208	3	r.	NORP
ajlsi-2730	208	4	huang	PERSON
ajlsi-2730	208	5	s.	PERSON
ajlsi-2730	208	6	2023	CARDINAL
ajlsi-2730	209	1	il17	PERSON
ajlsi-2730	210	1	8(1	CARDINAL
ajlsi-2730	210	2	402	CARDINAL
ajlsi-2730	211	1	m.	PERSON
ajlsi-2730	211	2	j.	PERSON
ajlsi-2730	211	3	j., & gostyński	ORG
ajlsi-2730	211	4	a.	PERSON
ajlsi-2730	211	5	2022	CARDINAL
ajlsi-2730	213	1	17(1	CARDINAL
ajlsi-2730	213	2	269	CARDINAL
ajlsi-2730	214	1	kim	PERSON
ajlsi-2730	214	2	m.	PERSON
ajlsi-2730	214	3	d.	NORP
ajlsi-2730	214	4	rangel	PERSON
ajlsi-2730	214	5	s. m.	PERSON
ajlsi-2730	214	6	a. b.	PERSON
ajlsi-2730	214	7	del duca	PERSON
ajlsi-2730	214	8	e.	GPE
ajlsi-2730	214	9	malik	PERSON
ajlsi-2730	214	10	k.	PERSON
ajlsi-2730	214	11	huynh	PERSON
ajlsi-2730	214	12	t., & ibler	ORG
ajlsi-2730	214	13	2022	CARDINAL
ajlsi-2730	216	1	142(9	DATE
ajlsi-2730	216	2	2363	CARDINAL
ajlsi-2730	218	1	lilly	ORG
ajlsi-2730	218	2	e., & bunick	ORG
ajlsi-2730	218	3	c. g.	PERSON
ajlsi-2730	218	4	2023	CARDINAL
ajlsi-2730	220	1	2473	CARDINAL
ajlsi-2730	221	1	martin-garcía	PERSON
ajlsi-2730	221	2	e., cabrera, a.	ORG
ajlsi-2730	221	3	j.	PERSON
ajlsi-2730	221	4	muñoz-bellido	PERSON
ajlsi-2730	221	5	f. j.	PERSON
ajlsi-2730	221	6	perez-pazos	PERSON
ajlsi-2730	221	7	j., & dávila	ORG
ajlsi-2730	221	8	i.	PERSON
ajlsi-2730	221	9	2023	CARDINAL
ajlsi-2730	222	1	two	CARDINAL
ajlsi-2730	223	1	37	DATE
ajlsi-2730	223	2	03946320231172881	DATE
ajlsi-2730	224	1	narbutt	PERSON
ajlsi-2730	224	2	j., niedźwiedź, m.	ORG
ajlsi-2730	224	3	lesiak	PERSON
ajlsi-2730	224	4	a.	GPE
ajlsi-2730	224	5	ceryn	GPE
ajlsi-2730	224	6	j., & skibińska	ORG
ajlsi-2730	224	7	m.	PERSON
ajlsi-2730	224	8	2023	CARDINAL
ajlsi-2730	225	1	secukinumab	PERSON
ajlsi-2730	226	1	421	CARDINAL
ajlsi-2730	227	1	sadik	PERSON
ajlsi-2730	227	2	c. d.	PERSON
ajlsi-2730	227	3	ludwig	ORG
ajlsi-2730	227	4	r. j.	PERSON
ajlsi-2730	227	5	d., & boch	ORG
ajlsi-2730	227	6	k.	PERSON
ajlsi-2730	227	7	2023	CARDINAL
ajlsi-2730	229	1	634	CARDINAL
ajlsi-2730	229	2	paller	ORG
ajlsi-2730	229	3	a. s.	PERSON
ajlsi-2730	229	4	2019	DATE
ajlsi-2730	231	1	139(3	DATE
ajlsi-2730	231	2	535-540	CARDINAL
ajlsi-2730	232	1	paller	ORG
ajlsi-2730	232	2	a. s.	PERSON
ajlsi-2730	232	3	renert-yuval	PERSON
ajlsi-2730	232	4	m.	PERSON
ajlsi-2730	232	5	m., huynh	PERSON
ajlsi-2730	232	6	t. n.	GPE
ajlsi-2730	232	7	b.	GPE
ajlsi-2730	232	8	kunjravia	GPE
ajlsi-2730	232	9	n., friedland	PERSON
ajlsi-2730	232	10	r., & peng	ORG
ajlsi-2730	232	11	x.	GPE
ajlsi-2730	232	12	2017	CARDINAL
ajlsi-2730	234	1	139(1	CARDINAL
ajlsi-2730	234	2	152	CARDINAL
ajlsi-2730	235	1	2022	CARDINAL
ajlsi-2730	236	1	70%	PERCENT
ajlsi-2730	237	1	14(9	CARDINAL
ajlsi-2730	238	1	s. i.	PERSON
ajlsi-2730	238	2	echeverria	PERSON
ajlsi-2730	238	3	m. d. l. d. c.	PERSON
ajlsi-2730	238	4	& leyva	ORG
ajlsi-2730	238	5	2023	CARDINAL
ajlsi-2730	240	1	14, 1274248	DATE
ajlsi-2730	241	1	pontello	ORG
ajlsi-2730	241	2	e.	GPE
ajlsi-2730	241	3	buffo	GPE
ajlsi-2730	241	4	s., & galeazzo	ORG
ajlsi-2730	241	5	2020	DATE
ajlsi-2730	244	1	european journal of pediatric dermatology	ORG
ajlsi-2730	244	2	104	CARDINAL
ajlsi-2730	245	1	m.	PERSON
ajlsi-2730	245	2	filippeschi	GPE
ajlsi-2730	245	3	f. a.	PERSON
ajlsi-2730	245	4	mori	PERSON
ajlsi-2730	245	5	f.	PERSON
ajlsi-2730	245	6	barni	GPE
ajlsi-2730	245	7	s.	GPE
ajlsi-2730	245	8	consonni	GPE
ajlsi-2730	245	9	f., & indolfi	ORG
ajlsi-2730	245	10	2022	CARDINAL
ajlsi-2730	247	1	10, 1074243	DATE
ajlsi-2730	248	1	roda	PERSON
ajlsi-2730	248	2	mendonça-sanches	PERSON
ajlsi-2730	248	3	m.	PERSON
ajlsi-2730	248	4	travassos	GPE
ajlsi-2730	248	5	a. r.	PERSON
ajlsi-2730	248	6	soares-de-almeida	PERSON
ajlsi-2730	248	7	l., & metze	ORG
ajlsi-2730	248	8	2017	CARDINAL
ajlsi-2730	249	1	infliximab	PERSON
ajlsi-2730	250	1	jaad	PERSON
ajlsi-2730	250	2	3(6	CARDINAL
ajlsi-2730	250	3	550	CARDINAL
ajlsi-2730	251	1	g.	PERSON
ajlsi-2730	251	2	marwaha	GPE
ajlsi-2730	251	3	r. k.	PERSON
ajlsi-2730	251	4	a.	GPE
ajlsi-2730	251	5	yenamandra	GPE
ajlsi-2730	251	6	v. k.	PERSON
ajlsi-2730	251	7	ramakrishnan	GPE
ajlsi-2730	251	8	l.	GPE
ajlsi-2730	251	9	thulkar	PERSON
ajlsi-2730	251	10	s., & sharma	ORG
ajlsi-2730	251	11	v. k.	PERSON
ajlsi-2730	251	12	2016	DATE
ajlsi-2730	254	1	137(1	DATE
ajlsi-2730	255	1	m.	PERSON
ajlsi-2730	255	2	2020	DATE
ajlsi-2730	256	1	2	CARDINAL
ajlsi-2730	257	1	153	CARDINAL
ajlsi-2730	258	1	takhtarova	GPE
ajlsi-2730	258	2	t. g.	PERSON
ajlsi-2730	258	3	khismatullina	GPE
ajlsi-2730	258	4	z. r.	PERSON
ajlsi-2730	258	5	panova	GPE
ajlsi-2730	258	6	l. d., & panova	PERSON
ajlsi-2730	258	7	a. n.	PERSON
ajlsi-2730	258	8	2021	CARDINAL
ajlsi-2730	260	1	6-13	DATE
ajlsi-2730	261	1	wang	PERSON
ajlsi-2730	261	2	m.	PERSON
ajlsi-2730	261	3	zhai	PERSON
ajlsi-2730	261	4	x.	GPE
ajlsi-2730	261	5	li	PERSON
ajlsi-2730	261	6	j., guan	PERSON
ajlsi-2730	261	7	j.	PERSON
ajlsi-2730	261	8	xu	PERSON
ajlsi-2730	261	9	s.	PERSON
ajlsi-2730	261	10	li	PERSON
ajlsi-2730	261	11	2021	CARDINAL
ajlsi-2730	263	1	12	CARDINAL
ajlsi-2730	263	2	670391	DATE
ajlsi-2730	264	1	yogarajah	PERSON
ajlsi-2730	264	2	j., gouveia	PERSON
ajlsi-2730	264	3	j.	PERSON
ajlsi-2730	264	4	a.	ORG
ajlsi-2730	264	5	nuoffer	ORG
ajlsi-2730	264	6	j.-m.	GPE
ajlsi-2730	264	7	m., & gautschi	ORG
ajlsi-2730	264	8	2021	CARDINAL
ajlsi-2730	265	1	abca12	DATE
ajlsi-2730	266	1	1(2	CARDINAL
ajlsi-2730	266	2	zaenglein	PERSON
ajlsi-2730	266	3	a. l.	PERSON
ajlsi-2730	266	4	m. l.	PERSON
ajlsi-2730	266	5	n. s.	PERSON
ajlsi-2730	266	6	benjamin	PERSON
ajlsi-2730	266	7	l. t., bruckner	PERSON
ajlsi-2730	266	8	a. l.	PERSON
ajlsi-2730	266	9	choate	ORG
ajlsi-2730	266	10	k.	PERSON
ajlsi-2730	266	11	b. g.	PERSON
ajlsi-2730	266	12	j. j.	PERSON
ajlsi-2730	266	13	eichenfield	GPE
ajlsi-2730	266	14	l. f., & elias	PERSON
ajlsi-2730	266	15	2021	CARDINAL
ajlsi-2730	268	1	38(1	CARDINAL
ajlsi-2730	268	2	164-180	CARDINAL